Core Scientific Inc (NASDAQ:CORZ)’s traded shares stood at 2.44 million during the latest session, with the company’s beta value hitting 6.84. At the last check today, the stock’s price was $12.51, to imply a decrease of -0.20% or -$0.02 in intraday trading. The CORZ share’s 52-week high remains $18.63, putting it -48.92% down since that peak but still an impressive 79.14% since price per share fell to its 52-week low of $2.61. The company has a valuation of $3.49B, with an average of 17.18 million shares in intraday trading volume over the past 10 days and average of 11.51 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Core Scientific Inc (CORZ), translating to a mean rating of 1.20. Of 6 analyst(s) looking at the stock, 0 analyst(s) give CORZ a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.03.
Core Scientific Inc (NASDAQ:CORZ) trade information
After registering a -0.20% downside in the latest session, Core Scientific Inc (CORZ) has traded red over the past five days. The 5-day price performance for the stock is 1.92%, and -11.44% over 30 days. With these gigs, the year-to-date price performance is -11.00%. Short interest in Core Scientific Inc (NASDAQ:CORZ) saw shorts transact 42.46 million shares and set a 4.43 days time to cover.
The extremes give us $14 and $24 for target low and target high price respectively. As such, CORZ has been trading -91.85% off suggested target high and -11.91% from its likely low.
Core Scientific Inc (CORZ) estimates and forecasts
Looking at statistics comparing Core Scientific Inc share performance against respective industry, we note that the company has underperformed competitors. Core Scientific Inc (CORZ) shares are 27.34% up over the last 6 months, with its year-to-date growth rate lower than industry average at -2,729.41% against 11.20%. The rating firms project that company’s revenue will grow 1.66% compared to the previous financial year.
Revenue forecast for the current quarter as set by 13 analysts is 97.21M. Meanwhile, for the current quarter, a total of 8 analyst(s) estimate revenue growth to 107.16M.Earnings reports from the last fiscal year show that sales brought in 141.93M and 179.29M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -31.51% before dropping -40.23% in the following quarter.
CORZ Dividends
Core Scientific Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Core Scientific Inc (NASDAQ:CORZ)’s Major holders
Core Scientific Inc insiders hold 10.93% of total outstanding shares, with institutional holders owning 68.77% of the shares at 77.21% float percentage. In total, 68.77% institutions holds shares in the company.
We also have Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Core Scientific Inc (CORZ) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 6.99 shares. This is just over 2.50% of the total shares, with a market valuation of $87.25 million. Data from the same date shows that the other fund manager holds a little less at 5.0, or 1.79% of the shares, all valued at about 62.39 million.
